Literature DB >> 25729946

Mitochondria-dependent apoptogenic activity of the aqueous root extract of Croton membranaceus against human BPH-1 cells.

D K Afriyie1, G A Asare2, K Bugyei3, J Lin1, J Peng1, Z Hong1.   

Abstract

Croton membranaceus aqueous root extract (CMARE) is among the widely used phytotherapeutics in Ghana for the management of benign prostatic hyperplasia (BPH) and prostate cancer. However, the mechanism of action of CMARE remains to be elucidated. This study aimed to establish whether apoptosis is involved in the antiproliferative effect of CMARE on human BPH-1 cells. We determined the effect of treatment with 0, 1, 3, and 5 mg/mL CMARE for 24, 48, and 72 h on the viability and morphology of BPH-1 cells using the MMT assay and phase-contrast microscopy, respectively. We examined the apoptosis-inducing effects of CMARE after 48 h at the cellular level using Hoescht 33258 and JC-1 dye staining and flow cytometry analysis. We performed reverse transcription polymerase chain reaction and Western blotting to confirm the apoptotic effects of CMARE at the molecular level. CMARE induced a significant dose-dependent inhibition in the proliferation of BPH-1 cells (P < 0.05) and an alteration in their morphology and a reduction their density. Furthermore, CMARE induced dose-dependent staining of the nuclear chromatin, significant DNA fragmentation with G₀/G₁ sub-diploid cells (P < 0.01), and loss of the mitochondrial membrane potential in the treated cells compared to the controls after 48 h (P < 0.01). Additionally, while CMARE induced a significant upregulation of the mRNA and protein levels of Bax, those of Bcl2 did not change significantly. Therefore, induction of mitochondria-dependent apoptosis of BPH-1 cells may be a possible mechanism of action of CMARE.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25729946     DOI: 10.4238/2015.January.15.18

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Traditional medicines and alternative practice in the management of prostate diseases in southern Ghana.

Authors:  Mathew Y Kyei; George O Klufio; Ali Ayamba; Sherif Mohammed
Journal:  Ghana Med J       Date:  2017-09

2.  Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract.

Authors:  George Awuku Asare; Daniel Afriyie; Robert A Ngala; Alfred A Appiah; Yvonne Anang; Iddi Musah; Samuel Adjei; Kwabena Bamfo-Quaicoe; Derick Sule; Ben A Gyan; Peter Arhin; Dominic A Edoh
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-02       Impact factor: 2.629

3.  Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug - Croton membranaceus Müll.Arg.

Authors:  George Awuku Asare; Robert A Ngala; Daniel Afriyie; Samuel Adjei; Adriana Nyarko; Yvonne Anang-Quartey; Bernice Asiedu; Derek Doku; Brodrick Y Amoah; Kennedy Bentum; Iddi Musah; Kensese Mossanda
Journal:  BMC Complement Altern Med       Date:  2017-03-11       Impact factor: 3.659

4.  Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance.

Authors:  Alexander L Semenov; Ekaterina A Gubareva; Elena D Ermakova; Anastasia A Dorofeeva; Irina A Tumanyan; Ekaterina A Radetskaya; Maria N Yurova; Saied A Aboushanab; Osman N Kanwugu; Elena I Fedoros; Andrey V Panchenko
Journal:  Plants (Basel)       Date:  2021-12-12

5.  Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients.

Authors:  George Awuku Asare; Yvonne Anang; Daniel K Afriyie; Brodrick Yeboah Amoah; Bernice Asiedu; Derek Doku; Hannah Serwah Ocansey; Nana Yaw Odei Danso; Prince Tekpor; Sarah Osam
Journal:  Medicines (Basel)       Date:  2017-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.